Many types of nanoparticles can cross the cell membrane and deliver their therapeutic payload into tumor cells. In some instances, however, nanoparticles can become trapped inside endosomes, distinct compartments within a cell in which enzymes can break down some anticancer agents. As a result, anticancer genes or drugs that must reach the nucleus in order to kill the cell may never reach their intended destination intact.